Sugi Predict

Sugi Predict / Compounds / SCHEMBL31682896

SCHEMBL31682896

SCHEMBL31682896

CC(=O)N[C@@H]1[C@@H](O[C@@H]2O[C@H](CO[C@@H]3O[C@H](CO[C@]4(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O4)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H](CO)O[C@H]1O

nearest known ligand 0.66

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ SIGLEC7 Q9Y286 6/20 0.66
▸ MAG P20916 10/20 0.64
▸ SELL P14151 1/20 0.58
▸ SELP P16109 1/20 0.58
▸ SELE P16581 1/20 0.50
▸ CD22 P20273 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29532284 0.97 MAG (0.67) SIGLEC7MAGSELLSELPCD22
SCHEMBL29580672 0.97 MAG (0.67) SIGLEC7MAGSELLSELPCD22
SCHEMBL30458098 0.97 MAG (0.67) SIGLEC7MAGSELLSELPCD22
SCHEMBL31717084 0.93 MAG (0.67) SIGLEC7MAGSELLSELPSELE
SCHEMBL29432525 0.92 SIGLEC7 (0.67) SIGLEC7MAGSELLSELPCD22
SCHEMBL6277035 0.92 SIGLEC7 (0.67) SIGLEC7MAGSELLSELPCD22
SCHEMBL31614392 0.92 SIGLEC7 (0.69) SIGLEC7MAGSELLSELPSELE
SCHEMBL31716429 0.92 SELP (0.66) SIGLEC7MAGSELLSELPSELE
SCHEMBL30970760 0.91 SIGLEC7 (0.70) SIGLEC7MAGSELLSELPSELE
SCHEMBL31700860 0.91 SIGLEC7 (0.68) SIGLEC7MAGSELLSELPSELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250281590-A1 IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED ESCHERICHIA COLI SACCHARIDES AND USES THEREOF PFIZER (US) 2025-09-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250281590-A1 IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED ESCHERICHIA COLI SACCHARIDES AND USES THEREOF C5AR1, C3AR1, C5 SIGLEC7 12/4885MAG 492/4885SELL 140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback